Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sanara MedTech Inc. (SMTI) and Encourages Investors to Learn More About the Investigation

Thursday, 14 May 2026 11:00 AM

Topic: 

Class Action

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sanara MedTech Inc. ("Sanara" or "the Company") (NASDAQ:SMTI). Investors who purchased Sanara securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SMTI.

 

Sanara Investigation Details

On November 11, 2025, Sanara announced that it would discontinue operations of its Tissue Health Plus ("THP") program. The Company claimed the decision was made to "reallocate resources to its core surgical business" and enhance "operating efficiency." The Company reported its Q3 2025 financial results the next day, including a "net loss from discontinued operations" of $31.2 million, with a $26.5 million charge tied to the THP program. Following this news, Sanara's stock price dropped by 24.7% on November 12, 2026.

What's Next for Sanara Investors?

If you are aware of any facts relating to this investigation or purchased Sanara securities, you can assist this investigation by visiting the firm's site: bgandg.com/SMTI. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to Sanara Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Sanara Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE: Bronstein, Gewirtz & Grossman, LLC